JP2024063214A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024063214A5 JP2024063214A5 JP2024034717A JP2024034717A JP2024063214A5 JP 2024063214 A5 JP2024063214 A5 JP 2024063214A5 JP 2024034717 A JP2024034717 A JP 2024034717A JP 2024034717 A JP2024034717 A JP 2024034717A JP 2024063214 A5 JP2024063214 A5 JP 2024063214A5
- Authority
- JP
- Japan
- Prior art keywords
- invention described
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024034717A JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2018/062534 WO2020112086A1 (en) | 2018-11-27 | 2018-11-27 | Methods of treating myeloproliferative disorders |
| JP2021530108A JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
| JP2024034717A JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Division JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024063214A JP2024063214A (ja) | 2024-05-10 |
| JP2024063214A5 true JP2024063214A5 (enrdf_load_html_response) | 2024-08-08 |
Family
ID=64734125
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Active JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
| JP2024034717A Pending JP2024063214A (ja) | 2018-11-27 | 2024-03-07 | 骨髄増殖性障害を治療する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021530108A Active JP7453230B2 (ja) | 2018-11-27 | 2018-11-27 | 骨髄増殖性障害を治療する方法 |
Country Status (8)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020112939A1 (en) | 2018-11-27 | 2020-06-04 | Constellation Pharmaceuticals, Inc. | Methods of treating myeloproliferative disorders |
| BR112022022986A2 (pt) | 2020-05-13 | 2023-01-17 | Disc Medicine Inc | Anticorpos anti-hemojuvelina (hjv) para tratar mielofibrose |
| EP4192470A1 (en) * | 2020-08-04 | 2023-06-14 | Constellation Pharmaceuticals, Inc. | 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide for treating thrombocythemia |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR084070A1 (es) * | 2010-12-02 | 2013-04-17 | Constellation Pharmaceuticals Inc | Inhibidores del bromodominio y usos de los mismos |
| CA2952830C (en) | 2014-06-20 | 2022-11-01 | Constellation Pharmaceuticals, Inc. | Crystalline forms of 2-((4s)-6-(4-chlorophenyl)-1-methyl-4h-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide |
-
2018
- 2018-11-27 KR KR1020247040010A patent/KR20250004357A/ko active Pending
- 2018-11-27 AU AU2018451360A patent/AU2018451360B2/en active Active
- 2018-11-27 EA EA202191489A patent/EA202191489A1/ru unknown
- 2018-11-27 SG SG11202105279SA patent/SG11202105279SA/en unknown
- 2018-11-27 JP JP2021530108A patent/JP7453230B2/ja active Active
- 2018-11-27 BR BR112021010134-9A patent/BR112021010134A2/pt unknown
- 2018-11-27 WO PCT/US2018/062534 patent/WO2020112086A1/en not_active Ceased
- 2018-11-27 CA CA3120973A patent/CA3120973A1/en active Pending
- 2018-11-27 KR KR1020217019508A patent/KR102738936B1/ko active Active
-
2024
- 2024-03-07 JP JP2024034717A patent/JP2024063214A/ja active Pending